P
TNDM icon

&Partners’s Tandem Diabetes Care TNDM Stock Holding History

&Partners’s Portfolio TNDM Stock Details TNDM Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q2 		– Sell
-23,142
Closed -$453K – 2037
2025
Q1 		$453K Buy
23,142
+15,946
+222% +$467K ﹤0.01% 1181
2024
Q4 		$265K Buy
+7,196
New +$243K ﹤0.01% 1400

Other funds holding TNDM

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
SC
Sessa Capital New York $5.51B AUM 47.23% 1-Year Est. Return
GKIM
GW&K Investment Management Boston, Massachusetts $11.3B AUM 31.98% 1-Year Est. Return
ACH
ArrowMark Colorado Holdings Denver, Colorado $3.76B AUM 21.77% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
HRCM
Hood River Capital Management Palm Beach Gardens, Florida $9.98B AUM 145.42% 1-Year Est. Return
Goldman Sachs
Goldman Sachs New York $871B AUM 31.28% 1-Year Est. Return
PIM
Paradice Investment Management Denver, Colorado $532M AUM 29.6% 1-Year Est. Return
SIMG
Stephens Investment Management Group Houston, Texas $7.3B AUM 41.96% 1-Year Est. Return

&Partners's TNDM Position: Q2 2025 in Review

&Partners sold out of Tandem Diabetes Care (TNDM) in Q2 2025, closing a stake of 23,142 shares — an estimated $453K sold.

&Partners first reported a position in TNDM in Q4 2024 and held it in 2 quarters. The position peaked at $453K in Q1 2025. 270 funds tracked by Wall St. Rank hold TNDM as of Q2 2025.

  • &Partners reported no remaining Tandem Diabetes Care position as of Q2 2025 after selling out during the quarter.
  • &Partners sold 23,142 Tandem Diabetes Care shares in Q2 2025, an estimated $453K.
  • &Partners first reported a position in Tandem Diabetes Care in Q4 2024 and held it in 2 quarters.
  • &Partners's Tandem Diabetes Care position peaked at $453K in Q1 2025.
  • 270 funds tracked by Wall St. Rank held Tandem Diabetes Care as of Q2 2025.

Based on &Partners's 13F filing for Q2 2025, filed 14 Aug 2025.